Carcinoma, Ovarian Epithelial: all 1,619 studies
Page 13 of 17. Open to participants first (245), then studies with results posted, then the rest; newest registration first within each.
- Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerCompletedNCT01459380Phase 1
- Safety of Active Immunotherapy in Subjects With Ovarian CancerStatus unknownNCT01456065Phase 1
- AZD2281 Plus Carboplatin to Treat Breast and Ovarian CancerCompletedNCT01445418Phase 1
- Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199WithdrawnNCT01445275
- Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian CancerCompletedNCT01442051Not applicable
- Juice Plus+ and Juice Plus+ Complete in Ovarian CancerActive, not recruitingNCT01439659Phase 2
- FES-PET to Determine ER-expression in Epithelial Ovarian CancerCompletedNCT01439490Phase 2
- Patient Reported Symptoms in Ovarian Cancer (PRECISION)CompletedNCT01422265
- Pilot Program to Personalize Care & Improve Quality of Life for Women With Ovarian CancerCompletedNCT01419210Not applicable
- Search for Predictors of Therapeutic Response in Ovarian CarcinomaCompletedNCT01391351Not applicable
- Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian CancerStatus unknownNCT01388621Phase 2
- Safety and Pharmacokinetics of Intraoperative Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) With Cisplatin to Treat Platinum-sensitive Recurrent Ovarian CancerStatus unknownNCT01387399Phase 1
- An Algorithm for Intra-operative Goal-directed Haemodynamic Management in Non-cardiac SurgeryCompletedNCT01384097
- INOVATYON STUDY -International, Randomized Study in Patients With Ovarian CancerCompletedNCT01379989Phase 3
- Characterization of Ovarian Cancer Stem CellStatus unknownNCT01367353Not applicable
- Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube CancerStatus unknownNCT01366183
- Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian CancerCompletedNCT01358071Phase 2
- Study of Circulating Tumoral DNA in Ovarian CancerCompletedNCT01350908Not applicable
- Safety and Pharmacokinetics of DMUC5754A Administered Intravenously to Patients With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic CancerCompletedNCT01335958Phase 1
- Blood Test for Ovarian Cancer Associated Auto AntibodiesStatus unknownNCT01334437
- Trial of Vaccine Therapy in Recurrent Platinum Sensitive Ovarian Cancer PatientsTerminatedNCT01334047Phase 1/2
- Search Allelic Imbalance of Expression of BRCA Genes in Hereditary Risk of Breast and/or Ovarian CancerCompletedNCT01333748Phase 2
- Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/PaclitaxelCompletedNCT01332656Phase 2
- Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian CancerCompletedNCT01322802Phase 1
- Therapeutic Targeting of Stress Factors in Ovarian Cancer PatientsCompletedNCT01308944Phase 1
- TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity CancerCompletedNCT01294293Phase 1
- Cancer Screening Program for Women at High Risk for Developing Ovarian CancerTerminatedNCT01292733Early Phase 1
- A Study of Carboplatin, PLD and Everolimus in Certain Gynecologic CancerCompletedNCT01281514Phase 1
- AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)TerminatedNCT01281254Phase 3
- Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian CancerTerminatedNCT01279291Phase 1
- Epithelial Ovarian Cancer- Staging and Response to Chemotherapy Evaluated by PET/CTActive, not recruitingNCT01276574
- A Trial to Evaluate Efficacy and Safety of the Combination Therapy of Genexol®-PM Plus Carboplatin® Compared to Genexol® Plus Carboplatin® as a Firstline Treatment in Subjects With Ovarian CancerCompletedNCT01276548Phase 2
- Circulating Lymphatic Progenitor Cell and Lymph Node MetastasisStatus unknownNCT01268956
- Clinical Trial Investigating Pazopanib in Patients With Platinum-resistant Advanced Ovarian CancerCompletedNCT01262014Phase 2
- Retrospective Study of Ovarian Cancer Patients With Brain MetastasisStatus unknownNCT01258881
- Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and SolidsCompletedNCT01256268Phase 1
- Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian CancerCompletedNCT01253681Phase 1
- Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV InfectionTerminatedNCT01249443Phase 1
- Catumaxomab as a Consolidation Therapy in Patients With Ovarian Cancer in Second or Third Clinical Disease RemissionCompletedNCT01246440Phase 2
- Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Ovarian Cancer and Peritoneal MetastasisCompletedNCT01242436Not applicable
- Phase I/II Study of Pazopanib and Cyclophosphamide in Patients With Platinum-resistant Recurrent Ovarian CancerCompletedNCT01238770Phase 1/2
- Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid TumorsTerminatedNCT01233505Phase 1
- MK-4827 in Combination With Pegylated Liposomal Doxorubicin in Participants With Advanced Solid Tumors and Ovarian Cancer (MK-4827-011)TerminatedNCT01227941Phase 1
- Study of Intraperitoneal Carboplatin with IV Paclitaxel and Bevacizumab in Untreated Ovarian CancerCompletedNCT01220154Phase 1
- Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian CancerSuspendedNCT01218490Phase 3
- Health and Coping Prior to Ovarian Cancer SurgeryCompletedNCT01213771Not applicable
- TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube CancerCompletedNCT01204749Phase 3
- Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian CancerTerminatedNCT01202890Phase 1
- Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian CancerCompletedNCT01196559Phase 2
- Short Non-coding RNA Biomarkers of Predisposition to Ovarian CancerStatus unknownNCT01187602
- Consolidation Whole Abdominal Intensity-Modulated Radiation Therapy (IMRT) in Advanced Ovarian CancerStatus unknownNCT01180504Phase 2
- Trial of High Dose Topotecan With Carboplatin in Patients With Relapsed Ovarian CarcinomaTerminatedNCT01177501Phase 1
- Use of Palliative Performance and Symptom Distress Scales in Older Patients With Advanced Ovarian CancerTerminatedNCT01175967
- Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment StrategyTerminatedNCT01175772Phase 2
- Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)TerminatedNCT01170650Phase 3
- Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian CancerCompletedNCT01166737Not applicable
- Study With Wee-1 Inhibitor AZD1775 (MK-1775) and Carboplatin to Treat p53 Mutated Refractory and Resistant Ovarian CancerCompletedNCT01164995Phase 2
- Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT01155258Phase 1
- A Dose-finding Study of RO5323441 in Patients With Metastatic Treatment-Refractory Colorectal or Ovarian CancerCompletedNCT01148758Phase 1
- N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian CancerWithdrawnNCT01138137Phase 1
- Autologous OC-DC Vaccine in Ovarian CancerCompletedNCT01132014Early Phase 1
- Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid TumorsCompletedNCT01131234Phase 1
- Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)CompletedNCT01126346Not applicable
- Study of the Combination Carboplatin Plus Celecoxib in Heavily Pre-treated Recurrent Ovarian Cancer PatientsCompletedNCT01124435Phase 2
- A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk WomenCompletedNCT01121640Not applicable
- A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian CancerCompletedNCT01113957Phase 2
- A 2 Stage Trial of Lenalidomide (REV) in Asymptomatic Ovarian Cancer Patients With Increasing CA 125 in Late RelapseCompletedNCT01111903Phase 1/2
- Study of Oral ENMD-2076 Administered to Patients With Ovarian CancerCompletedNCT01104675Phase 2
- Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast CancerCompletedNCT01104259Phase 1
- Collection of Tissue Samples From Patients With Stage III or Stage IV Ovarian Epithelial CancerCompletedNCT01096394
- Seprafilm™ for the Prevention of Intraperitoneal Adhesions and Improved Delivery of Therapy in Women Undergoing Staging and Intraperitoneal Chemotherapy for Advanced Ovarian CancerTerminatedNCT01095367Not applicable
- Intraoperative Hyperthermic Intraperitoneal Chemotherapy With Ovarian CancerCompletedNCT01091636Phase 2/3
- Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel ObstructionTerminatedNCT01083537Phase 1/2
- Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving ChemotherapyCompletedNCT01080521
- Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT01074411Phase 1
- Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182Status unknownNCT01074398
- Pathway to Diagnosis of Ovarian CancerStatus unknownNCT01061619
- Efficacy and Safety Study of Sorafenib With Topotecan in Patients With Platinum-resistant Recurrent Ovarian CancerCompletedNCT01047891Phase 2
- How Our Immune System Can Help Fight CancerCompletedNCT01042847
- M. D. Anderson Symptom Inventory - Ovarian CancerCompletedNCT01037751
- A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Resistant Recurrent Ovarian CancerCompletedNCT01033292Phase 2
- A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian CancerCompletedNCT01033123Phase 2
- Prolonged Emend in a Study (NYU 03-67) of Oxaliplatin and Topotecan in Previously Treated Ovarian CancerWithdrawnNCT01017809Not applicable
- A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian CancerTerminatedNCT01016054Phase 1
- Safety Study of Farletuzumab, Carboplatin and Pegylated Liposomal Doxorubicin (PLD) to Treat Platinum-sensitive Ovarian CancerCompletedNCT01004380Phase 1
- Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and PaclitaxelWithdrawnNCT01000896Phase 1
- Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00989651Phase 1
- Study of Paclitaxel in Patients With Ovarian CancerCompletedNCT00989131Phase 3
- Ovarian Cancer Risk Estimation in Patients With Pelvic MassCompletedNCT00987649
- Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian CancerCompletedNCT00986206
- A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian CancerStatus unknownNCT00982631Phase 1
- A Study of an Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic CancersCompletedNCT00964756Phase 1
- Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial CancerStatus unknownNCT00964626Phase 2
- Positron Emission Tomography/Computed Tomography (PET/CT) in Relapsed Ovarian Cancer (MK-0000-143)CompletedNCT00959582Phase 1
- Motion Correction in Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) in Ovarian Cancer: A Pilot StudyCompletedNCT00946140
- Whole Abdomen Radiation in Conjunction With Intraperitoneal Chemotherapy for the Treatment of Small Volume Recurrent Ovarian Carcinoma Limited to the Peritoneal CavityWithdrawnNCT00942838Phase 1
- Study of the mTOR Inhibitor Temsirolimus (CCI-779) to Treat Ovarian Cancer With CA125 Only RelapseTerminatedNCT00926107Phase 2
- Effects of a Teaching Intervention With an Advanced Practice Nurse on Quality of Life and Psychosocial and Symptom Distress in Patients With Ovarian CancerCompletedNCT00900679Not applicable
- Prostaglandin Metabolite in Urine Samples From Patients With Ovarian CancerCompletedNCT00900523
- Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial CancerStatus unknownNCT00900289